Semaglutide effects on human epicardial and subcutaneous fat released exosomes, aortic endothelial cells and neutrophils

Back

ESC Professional Premium Access

Semaglutide effects on human epicardial and subcutaneous fat released exosomes, aortic endothelial cells and neutrophils

Session: Inflammatory mechanisms in vascular disease

Topic: Leukocytes, Inflammation, Immunity

Speaker: Doctor S. Eiras (Santiago de Compostela, ES)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Sonia Eiras

Health Research Institute, Santiago de Compostela (Spain)

1 follower

6 more presentations in this session

PCSK9-inhibitor therapy leads to changes in immune cell gene expression and function: A subset analysis of the PACMAN-AMI trial

Speaker: Ms A. Ondracek (Vienna, AT)

Inclisiran reduces expression of Toll-like receptor-4 on circulating monocytes

Speaker: Mr J. Bernhard (Vienna, AT)

Bone-marrow-derived nerve growth factor receptor-positive dendritic cells contribute to the suppression of arterial remodelling via apoptosis

Speaker: Assistant Professor S. Takashima (Kanazawa, JP)

Phenylacetylglutamine causes a pathologic inflammation state and enhances atherosclerosis through the b2-adrenergic receptor cAMP PKA NF-kappaB pathway in diabetes.

Speaker: Doctor L. Huang (Shanghai, CN)

The COVID-19 mRNA vaccine Comirnaty induces anaphylactic shock in an anti-PEG hyperimmune large animal model

Speaker: Doctor B. Barta (Budapest, HU)

Access the full session

Inflammatory mechanisms in vascular disease

Speakers: Doctor S. Eiras, Ms A. Ondracek, Mr J. Bernhard, Assistant Professor S. Takashima, Doctor L. Huang...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

Semaglutide effects on human epicardial and subcutaneous fat released exosomes, aortic endothelial cells and neutrophils

About the speaker

Doctor Sonia Eiras

6 more presentations in this session

PCSK9-inhibitor therapy leads to changes in immune cell gene expression and function: A subset analysis of the PACMAN-AMI trial

Inclisiran reduces expression of Toll-like receptor-4 on circulating monocytes

Bone-marrow-derived nerve growth factor receptor-positive dendritic cells contribute to the suppression of arterial remodelling via apoptosis

Phenylacetylglutamine causes a pathologic inflammation state and enhances atherosclerosis through the b2-adrenergic receptor cAMP PKA NF-kappaB pathway in diabetes.

The COVID-19 mRNA vaccine Comirnaty induces anaphylactic shock in an anti-PEG hyperimmune large animal model

Access the full session

Inflammatory mechanisms in vascular disease

About the event

ESC Congress 2023

ESC 365 is supported by